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Summary
Although hippocampal neurons are well-distinguished by the morphological characteristics of their dendrites and their structural
plasticity, the mechanisms involved in regulating their neurite initiation, dendrite growth, network formation and remodeling are still
largely unknown, in part because the key molecules involved remain elusive. Identifying new dendrite-active cues could uncover
unknown molecular mechanisms that would add significant understanding to the field and possibly lead to the development of novel
neuroprotective therapy because these neurons are impaired in many neuropsychiatric disorders. In our previous studies, we deleted the
gene encoding CRMP3 in mice and identified the protein as a new endogenous signaling molecule that shapes diverse features of the
hippocampal pyramidal dendrites without affecting axon morphology. We also found that CRMP3 protects dendrites against dystrophy
induced by prion peptide PrP106–126. Here, we report that CRMP3 has a profound influence on neurite initiation and dendrite growth of
hippocampal neurons in vitro. Our deletional mapping revealed that the C-terminus of CRMP3 probably harbors its dendritogenic
capacity and supports an active transport mechanism. By contrast, overexpression of the C-terminal truncated CRMP3 phenocopied the
effect of CRMP3 gene deletion with inhibition of neurite initiation or decrease in dendrite complexity, depending on the stage of cell
development. In addition, this mutant inhibited the activity of CRMP3, in a similar manner to siRNA. Voltage-gated calcium channel
inhibitors prevented CRMP3-induced dendritic growth and somatic Ca2+ influx in CRMP3-overexpressing neurons was augmented
largely via L-type channels. These results support a link between CRMP3-mediated Ca2+ influx and CRMP3-mediated dendritic growth
in hippocampal neurons.
Key words: CRMP3, Dendrite morphogenesis, Neurite initiation, Ca2+ flux, Lamellipodia, Hippocampal neurons

Introduction
Dendritic arbors of neurons play a central role in brain
development and plasticity as their specific features provide the
structural support for connectivity and information processing.
Despite the great diversity between neuronal types, most vertebrate
nerve cells exhibit distinctive dendrititic morphology depending
on their location. These dendrite characteristics influence the
electrical and chemical signals that a neuron receives, and
consequently impact the neuronal network assembly and
function. The dendritic arbor emerges as a convergent product of
specific patterns of growth, branching and retraction and is
differentially regulated at several points, including control of the
number of dendrites, primary branches and their mode and
frequency of branching. The balance between growth, retraction

and stabilization of dendritic branches persists throughout lifetime
(Sakisaka et al., 2004; Huang et al., 2007; Georges et al., 2008; Lin
and Koleske, 2010; Kulkarni and Firestein, 2012). As a
consequence, studies on dendrite morphogenesis seek, not only
to examine their developmental origins such as neurite initiation
and dendrite specification and growth (Barnes and Polleux, 2009;
Emoto, 2011; Cheng and Poo, 2012), but also to uncover the
mechanisms of their inherent remodeling plasticity.
Manipulation of gene expression both in vivo and in vitro
provides excellent paradigms to uncover a regulatory role for a
protein in maintaining neuronal polarity and plasticity. The
primary hippocampal neuron is one of the most widely used
culture systems for investigating neuronal differentiation and
regulation. A few hours after plating, neurons extend minor
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neurites; then one of them extends rapidly and by morphological
transformation generates the axon through stochastic selection.
The other neurites mature into dendrites, establishing neuronal
polarity (Dotti et al., 1988; Calderon de Anda et al., 2008).
Because neurons in culture develop polarity without exogenous
guidance or neurotropic cues, it is believed that an internal
polarization program exists involving several intra-neuronal
organelles and distinct repertoires of signaling molecules
intrinsic to the neuron (Goldberg, 2004). Extrinsic signals such
as neurotrophins (Song and Poo, 1999), attractant and repellent
guidance cues such as semaphorins (Fiore and Püschel, 2003;
Schlomann et al., 2009) and guide-post proteins released by
guide-post cells (Palka et al., 1992) provide short and long range
guidance information. These signals can also stably change the
intrinsic ability of neurons to extend or retract neurites during
development (Vanderhaeghen and Polleux, 2004) or to engage
them into an axono-dendritic differentiation path (Horton and
Ehlers, 2003). Extracellular matrix (ECM) proteins such as
collagen, laminin and fibronectin also influence neurite
development (Lein and Higgins, 1989; Boisseau and
Simonneau, 1989; Chamak and Prochiantz, 1989), and together,
these various factors provide dendrites with proper routing
information to reach appropriate targets or cover appropriate
receptive areas (Polleux et al., 2000; Mitsui et al., 2002).
Although the mechanisms underlying dendrite development are
still largely unknown, recent studies have shown that the Rho
family small GTPases are mediators of dendritic morphogenesis
through cytoskeleton remodeling (Luo, 2002; Van Aelst and
Cline, 2004; Arimura et al., 2000). For instance, cypin increases
dendrite morphogenesis by binding directly to tubulin (Akum
et al., 2004), and this function is linked to RhoA activity (Chen
and Firestein, 2007). However, erbin and d-catenin, which
regulate dendrite branching without affecting number of
dendrites, act independently from RhoA and Rac1 (Arikkath
et al., 2008).
It has generally been assumed that the axon-dendrite polarity
involves distinct repertoires of signaling proteins. Overexpression
of LKB1/STRAD (Shelly et al., 2007) or CRMP2 (Arimura et al.,
2004) promotes multiple axon formation in cultured hippocampal
neurons, whereas cypin (Akum et al., 2004), erbin and d-catenin
(Arikkath et al., 2008), and endogenous Rac1 (Gualdoni et al.,
2007), Cdc42 (Chen et al., 2012) and Rab17 (Mori et al., 2012)
activities are critical for dendrite development. In contrast,
CRMP4 and CRMP5 suppress dendritic branching (Niisato et al.,
2012; Brot et al., 2010). Despite these recent observations, the
mechanisms involved in early events of neuronal differentiation,
such as neurite initiation and maturation into dendrites are still
poorly understood (Barnes and Polleux, 2009). Therefore, the
identification and characterization of new molecules playing a
role in dendrite morphogenesis are critical for the elucidation of
the cellular and molecular mechanisms that underlie the
generation/maintenance of dendrite arborization. CRMP3 is
highly expressed in the brain during embryonic development
but is localized mostly in hippocampus post-natally. As there is a
spatial and temporal correlation between the pattern of
expression of CRMP3 and the timing of neurite outgrowth and
the distribution of dendritic plasticity, we investigated the role of
CRMP3 by targeted-disruption of the CRMP3 gene and
established a line of CRMP32/2 mice. We found that CRMP3
regulates dendritic complexity in vertebrate hippocampal neurons
in vivo. CRMP32/2 animals displayed alterations in the
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morphology of dendrites and spines in developing hippocampal
neurons that persisted in adult mice. In addition, they exhibited
hippocampal-dependent functional impairment with abnormal
long-term potentiation (LTP), a deficit in prepulse inhibition
(PPI) (Quach et al., 2008a; Quach et al., 2008b) and a significant
increase in sensitivity to neurotoxin-induced kindling (T.T.Q.,
unpublished results). We also showed that overexpression of
CRMP3 prevented dendrito-toxicity induced by prion peptide
PrP106–126 in vitro, suggesting that CRMP3 has a role in
neuroprotection of hippocampal neurons (Quach et al., 2011).
This set of convergent results provides evidence that CRMP3
might be a novel neurite or dendrite outgrowth regulator and
because its expression is maintained throughout life in the
hippocampus, it could play a critical role in hippocampal
function and plasticity, and might be involved in aging and the
pathophysiology of neurodegenerative disorders.
Despite these observations, little is known of how dendritic
development is regulated by CRMP3. Several observations
suggest that Ca2+ signaling via Ca2+ channels and by release of
intracellular stores influence the growth and branching of
dendrites and the formation of spines (Lohmann, 2009; Yu and
Goda, 2009; Puram et al., 2011). In particular, it has been shown
that local Ca2+ signaling regulates filopodia dynamics (Lohmann
et al., 2005) and influences dendrite branching (Konur and
Ghosh, 2005). In line with these observations, our recent studies
linked the canonical roles of CRMPs in the specification of
neuronal structure and function (Charrier et al., 2003) to the
activation of neuronal voltage-gated Ca2+ channels (VGCCs)
(Chi et al., 2009; Wang et al., 2010; Brittain et al., 2011). Our
previous work using whole-cell voltage clamp electrophysiology
has also shown that CRMP3 enhances Ca2+ current density via
VGCCs in transfected hippocampal neurons (Quach et al., 2011).
Here, we report, for the first time, that CRMP3 expression affects
neurite initiation, primary dendrite formation and branching
without affecting axon morphology. We also show that this
activity resides in the C-terminus of the protein and that Ca2+
influx, largely via L-type Ca2+ channels, might be involved in
CRMP3-mediated dendritogenic activities in hippocampal
neurons.
Results
CRMP3 expression controls neurite initiation and
dendrite morphogenesis

CRMP3 is highly expressed in adult hippocampus. To determine
its role we created a CRMP32/2 mouse line and found that during
early post-natal development, hippocampal pyramidal neurons in
these mice displayed dendritic dystrophy that persisted throughout
adulthood (Quach et al., 2008a). To complement our in vivo
observations, in this study we examined the role of CRMP3 on
dendrite development in vitro using cultured hippocampal cells
from CRMP32/2, CRMP3+/2 and wild-type (WT) mice.
Hippocampal neurons (stained with b-III tubulin, a neuronal
marker) prepared from WT mice and grown for 6 days in vitro
(d.i.v.), displayed a single axon (as assessed by staining with the
axonal marker Tau) as well as several dendrites identified by
staining with an antibody against microtubule-associated protein
(MAP2; supplementary material Fig. S1A,B). In marked contrast,
CRMP32/2 hippocampal neurons, identified as LacZ positive
by b-galactosidase activity (LacZ+, Fig. 1Ai, white arrow) or
immunostaining with anti-b-galactosidase antibody (b-gal,
Fig. 1Aiii) exhibited a very different morphology with a
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Fig. 1. Deleting CRMP3 curbs neurite initiation and dendrite
morphogenesis. (A) Representative LacZ+/CRMP32/2 (blue) cell with no
processes (i, white arrow) and LacZ2 cell with neurites (i, black arrow) after
10 d.i.v detected using b-galactosidase activity. Colocalization of CRMP32/2
cell with neurofilament 200 (NF200, ii) and anti-b-galactosidase (b-gal)
antibodies (iii). Representative LacZ+/CRMP3+/2 cell bearing neurites
(iv, white arrows) co-stained with NF200 (v) and anti-b-gal antibodies (vi).
(B) Representative CA1 hippocampal sections from 10-day-old CRMP32/2
(i,ii) and CRMP3+/2 (iii,iv) mice immunostained with MAP2 (i,iii) and
NF200 (ii,iv). Scale bars: 15 mm (A); 30 mm (B).

complete absence of neurites. These cells displayed only short and
round processes that did not evolve beyond stage 1 of neuronal
differentiation (Banker and Cowan, 1979), even after 10 d.i.v.
Staining with NF200, a neuronal marker (Fig. 1Aii) and with
MAP2 (supplementary material Fig. S2), confirmed that these cells
were neurons. Normal neurite initiation and formation were
observed in cultures of hippocampal neurons prepared from
heterozygous CRMP3+/2 mice (Fig. 1Aiv–vi). Altered cellular
phenotypes were also evident by immunostaining of hippocampus
with a scarcity of neurites in CRMP32/2 (Fig. 1Bi–ii) whereas
neuronal processes appeared normal in CRMP3+/2 (Fig. 1Biii–iv).
In addition, although the main structure of the hippocampus was
not grossly altered (supplementary material Fig. S3A–D), there
was a small but significantly higher presence of ectopic pyramidallike cells in stratum oriens that could underlie the differential
migratory response of these neurons to CRMP3 (supplementary
material Fig. S4A–B).
Our results from gene targeting support the hypothesis that
CRMP3 is involved in dendritic development and might be a
positive regulator of dendrite formation. To determine whether
CRMP3 influences early morphogenetic events in cultured
hippocampal neurons, we quantified the effect of increasing
CRMP3 expression on the development of neuronal polarity and
dendritogenesis. CRMP3 full-length cDNA was tagged with
FLAG (Fig. 2A), 1 mg FL-CRMP3 DNA was transfected at 3
d.i.v. and the phenotype of transfected cells analyzed 72 hours
later. The dendritic arbor of neurons transfected with control
plasmid (Fig. 3C) and untransfected neurons was similar.
Remarkably, 70–75% of the FL-CRMP3-expressing neurons
developed both abundant short neurites and long highly
branching neurites (Fig. 3A). These neurites exhibited the
characteristic of dendrites with positive immunoreactivity for
MAP2 (Fig. 3A) and no immunoreactivity for the axonal marker,
Tau1 (not shown), therefore, these processes are likely dendrites.
Quantitative analyses demonstrated that CRMP3-expressing
neurons had a large increase in number of primary dendrites
(Fig. 3F), total branching points (Fig. 3G) and total dendritic
length (Fig. 3H) compared with untransfected or GFP-transfected
cells, suggesting that CRMP3 regulates dendritogenesis and

Fig. 2. Homology model of CRMP3 and N- and C-terminus constructs.
(A) Linear schematic of CRMP3 constructs. The italicized numbers refer to
the amino acids denoting the locations of the N- and C-terminus truncations
and the site of the FLAG epitope. A homology model of CRMP-3 [(ribbon
representations (B,C); surface representation (D)] was constructed based on
the crystal structure of CRMP-1 (PDB: 1KCX) using SWISS-MODEL
workspace (Arnold K. et al., 2006). The QMEAN4 global score, a composite
scoring function for both the estimation of the global quality of the entire
model, as well as for the local per-residue analysis of different regions within
a model, was 0.67 with a z-score of 21.67. The structures of full-length
CRMP3 (B,C), a construct lacking amino acids 1–132 (CRMP3DN; B), and a
construct lacking amino acids 434–572 (CRMP3DC; C,D) are illustrated. The
surface representation of one monomer (D) illustrates the largely surface
exposed residues (highlighted in red) that were deleted in the CRMP3DC
construct. For clarity, only dimers are shown. The rotational axes are as
indicated.

dendrite arborization. Interestingly, FL-CRMP3-transfected
neurons were often (.75%) surrounded by an extensive
prominent thin sheet-like lamellipodium (Fig. 3B, yellow
arrows; Fig. 4E, white arrowheads), not present in GFPtransfected or untransfected neurons. Lamellipodium has been
shown to strongly influence neurite initiation and filopodia
genesis, and to be indispensable for successful dendrite
elaboration (Dotti et al., 1988; Yamaguchi et al., 2009). The
widespread presence of CRMP3 puncta in the lamellipodium
(Fig. 4E) suggests a link between CRMP3 expression and
lamellipodial formation.
Dendritogenic activity of CRMP3 resides in its C-terminus

We next investigated which region within CRMP3 is responsible
for its dendritogenic activity. To map the domains that possibly
impart this activity, we relied on a series of published findings as
a guide for the design of CRMP3 constructs. First, a previous
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Fig. 3. Dendritogenic activity of CRMP3 resides in its C-terminus. Dissociated 3 d.i.v. hippocampal neurons were transfected with 1 mg FL-CRMP3
(A,B), CRMP3DN (D), CRMP3DC (E) or GFP control DNA (C) and fixed at 6 d.i.v. Representative transfected neurons immunostained for FLAG (red) and
dendritic marker MAP2 (green). Overlay images of transfected neurons are in yellow. Note the morphological features of FL-CRMP3- and CRMP3DN-transfected
neurons characterized by an increase in lamellipodial formation (yellow arrows in B,D) and dendritic arborization. Quantitative analyses of hippocampal neurons
expressing FL-CRMP3 and CRMP3DN had significantly more primary dendrites (F), branching points (G) and total dendritic length (H) compared with
untransfected and GFP-transfected neurons. Quantitative analyses showed a significant decrease in dendrite number, length, branching and length of longest
dendrite in CRMP3DC-transfected cells compared with untransfected and GFP-transfected cells (G–I). Data are expressed as means 6 s.e.m. of 40–60 neurons per
group, and values that differ significantly from GFP-transfected neurons (Student’s t-test) are indicated as follows: *P,0.01, FL-CRMP3 or CRMP3DN- or
CRMP3DC-transfected neurons versus GFP-transfected neurons; #P,0.05, CRMP3DC-transfected neurons versus GFP-transfected neurons. Scale bars: 50 mm.

study had implicated the C-terminus of the related CRMP5
protein CRMP5DC472 as important for morphogenesis of
hippocampal dendrites (Brot et al., 2010). Second, deletion of
the C-terminus in CRMP2 resulted in loss of its axon-promoting
effect (Inagaki et al., 2001). Finally, it was found that mutating a
tyrosine kinase site within the C-terminus of CRMP2, resulted in
loss of function of CRMP2 (Varrin-Doyer et al., 2009), and this
site is also conserved in CRMP3. Additionally, based on the
published crystal structure of CRMP1 (Deo et al., 2004), we
developed a homology model of CRMP3 (Fig. 2B–D). This
predicted structure revealed that large parts of the C-terminus are
surface exposed, not involved in CRMP tetramerization, and
therefore could possibly harbor the dendritogenic activity.
Reasoning that the CRMP3 C-terminus might harbor its
activity, we created FLAG-tagged CRMP3 constructs lacking
either the C-terminus (CRMP3DC) or the N-terminus
(CRMP3DN) (Fig. 2A), then transfected them into WT
hippocampal neurons. Similar to neurons transfected with FLCRMP3 (Fig. 3A), the CRMP3DN-transfected neurons were
surrounded by lamellipodia and exhibited extensive dendrite
formation (Fig. 3D), suggesting that the N-terminus domain is
not necessary for constitutive CRMP3 dendritogenic activity. In
contrast, we found that cultured WT hippocampal neurons
transfected at 3 d.i.v. with CRMP3DC (Fig. 3E) had
significantly shorter dendrites when compared to neurons

expressing GFP–control (Fig. 3C), with a significant decrease
in branching points (Fig. 3G), total dendritic length (Fig. 3H) and
also longest dendrite length (Fig. 3I). Thus, the deletion of 139
amino acids from the C-terminus was sufficient to convert the
dendrite-inducing activity to an inhibitory one. Interestingly,
when WT neurons were transfected with CRMP3DC at 15 hours
after plating instead of 3 d.i.v. they did not develop neurites
(Fig. 4A1,A2). Their morphology was very similar to the one
observed in CRMP32/2 cultured neurons (Fig. 1Ai–iii). Staining
with neurofilament, a neuronal marker, confirmed that these cells
were neurons (Fig. 4B1–B3), and staining with TUNEL showed
that they were not apoptotic (Fig. 4C1–C4). Our current
observations support the concept that CRMP3 regulates not
only dendrite growth, but also neurite initiation.
To determine whether the CRMP3DC truncated protein can
directly compete and inhibit the activity of FL-CRMP3 on
dendrite arborization, we co-transfected hippocampal neurons
with the two plasmids. The C-terminus-deleted CRMP3 exerted
a dominant-negative effect on the FL-CRMP3 protein by
preventing CRMP3-induced increase in dendritogenesis
(Fig. 5B), whereas co-expression of a control GFP protein had
no effect (Fig. 5A). Quantitative analyses revealed that,
compared with the GFP+FL-CRMP3 co-transfection condition,
neurons transfected with CRMP3DC+FL-CRMP3 had a
significant reduction in the number of primary neurites per
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Fig. 4. Early transfection of CRMP3DC prevents neurite initiation. Representative neuron transfected with CRMP3DC at 15 hours in culture, stained for
MAP2 (A1, green) and for FLAG peptide (inset of A2, red). A2 shows merged image. Note the absence of neurites in cells transfected early after plating, similar
to cultured CRMP32/2 neurons (Fig. 1Ai–iii). These cells express neurofilament: transfected neurons co-stained with FLAG (red), neurofilament (green) and
DAPI (blue) are shown in B1, B2 and inset of B3, respectively. B3 shows merged image (white arrow, untransfected cell; yellow arrow, transfected neuron).
(C) TUNEL staining. The transfected cells are not apoptotic: note three cell nuclei stained with DAPI (C1); only the top cell nucleus (C2) is TUNEL+. CRMP3DCtransfected cell (C3) is TUNEL2 (n521; all negative). C4 is the merged image. Puncta distribution of CRMP3. The distribution of FL-CRMP3 puncta in dendrites
(white arrows) and in lamellipodial formation (white arrowheads) of FL-CRMP3-transfected neurons (0.4 mg/well for 24 hours) shown in E contrasts with the
absence of FLAG–(1–150 aa)DCRMP3 dendritic distribution in FLAG–(1–150 aa)DCRMP3-transfected neurons (0.4 mg or 1.0 mg/well for 24 hours) shown in D.
The truncated protein was confined to the cell body. n520–25 neurons/group. Scale bars: 30 mm.

Fig. 5. Co-transfection with CRMP3DC or siRNA
knockdown of CRMP3 prevents FL-CRMP3-induced
increase in dendrite arborization. Representative images
of cultured hippocampal cells co-transfected with FLCRMP3 (1 mg/well) and GFP (1 mg/well) (A; stained for
GFP and MAP2, inset) or with FL-CRMP3 (1 mg/well)
and CRMP3DC (1 mg/well) (B; stained for FLAG).
Quantitative analysis of dendrite characteristics is shown
in E–G. Representative images of cultured hippocampal
neurons co-transfected with FL-CRMP3 (1 mg/well) and
scramble siRNA (1 mg/well) (C) or CRMP3 siRNA (1 mg/
well) (D) stained with FLAG antibody. Quantitative
analysis of dendrite characteristics (Student’s t-test) is
shown in E–G. *P,0.05, FL-CRMP3+CRMP3DCtransfected neurons versus FL-CRMP3+GFP-transfected
neurons; n520–27. NP,0.05 FL-CRMP3+CRMP3 siRNA
compared with FL-CRMP3+Sc-siRNA; n517–22). Scale
bars: 25 mm.
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neuron (Fig. 5E), and in total dendritic length (Fig. 5G). To
confirm the role of CRMP3 in dendrite regulation, we used short
interfering RNA (siRNA). The dominant-negative phenotype of
CRMP3DC was phenocopied in neurons co-transfected with
CRMP3 and a short interfering RNA (siRNA) against CRMP3
(Fig. 5D) whereas a control scramble siRNA had no effect on
dendritic parameters (Fig. 5C). Quantitative analysis revealed a
significant decrease in the number of primary dendrites, number
of branching points and total dendritic length with CRMP3
siRNA (Fig. 5E–G), with no effect for scrambled siRNA. In all,
our findings show that CRMP3DC, which lacks the C-terminus of
CRMP3, acts in a dominant-negative fashion to suppress
dendritic morphogenesis.
Confocal analyses of FLAG immunofluorescence showed that
FL-CRMP3 preferentially distributes in the soma and dendrites of
transfected hippocampal neurons (data not shown). The proteins
probably contain a ‘zipcode motif’ that is critical for the targeting
to dendrites. Whereas the axonal function of CRMP2 has been
linked to the formation of the CRMP2–Sra-1–WAVE–Kinesin
cargo complex, suggesting the active transport of CRMP2 into
the axon (Kawano et al., 2005; Namba et al., 2011), mechanisms
underlying the dendritic distribution of CRMP3 are unknown. In
a first attempt to determine whether CRMP3 requires similar
active transport process, we transfected hippocampal neurons
with FL-CRMP3 (0.4 mg/well) for only 24 hours. At this time
and dose, rather than a passive lateral diffusion, the protein
presented as puncta in the soma and dendrites with some puncta
extending in to the dendritic tips (Fig. 4E, white arrows).
Comparison with the more intense and homogenous
distribution of CRMP3 in dendrites seen at a later time
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(Fig. 3A) suggests a directional movement of CRMP3 from
the soma to the dendrites. As CRMP3DN was also found in
dendrites and retains CRMP3 activity in dendrite formation,
we hypothesized that the cargo binding or transport signal
sequence is not present in the 1–150 deleted amino acids of
CRMP3DN. To control the selectivity and effectiveness of FLCRMP3 puncta directional drift movement, we constructed
and expressed these 150 amino acid tagged with FLAG
[FLAG–(1–150)DCRMP3]. Consistent with our hypothesis,
we found that FLAG–(1–150)DCRMP3 was confined in cell
bodies and was absent in dendrites (Fig. 4D). None of
the FLAG–(1–150)DCRMP3-transfected neurons exhibited
dendritic FLAG staining, suggesting that the first 150 amino
acids from the N-terminus are not associated with active
dendritic transport.
CRMP3 does not modify axon morphology

To confirm that CRMP3 affects primary neurites and dendrites
but not axons, after axonal specification has occurred, the role of
CRMP3 on axonal growth was also investigated. We did not
detect any significant changes in the architecture of axons in
neurons transfected with FL-CRMP3 or CRMP3DN at 3 d.i.v.
Neurons had only one axon identified by co-immunostaining of
Tau-1 and FLAG without any significant qualitative or
quantitative morphological change (Fig. 6). Characteristics of
axons of CRMP3DC and FL-CRMP3-transfected neurons were
not significantly different from those of control GFP-vector
transfected neurons. The absence of significant change in axon
morphology, including length (Fig. 6C) and number of branching
points (Fig. 6D), corroborates the notion that axonal growth is

Fig. 6. CRMP3 overexpression and deletion of CRMP3 C-terminus does not affect axon morphology. Representative images of FLAg-antibody-stained
(A1,B1 inset) neurons transfected with full-length FL-CRMP3 (A) or CRMP3DC (B). Cells were co-stained with the axonal antibody Tau (A2, B3) or MAP2 (B1).
The merged images are shown in A3 and B2. White arrows, axon and axonal projection; white arrowheads, untransfected neurons in the field. Quantitative
analyses of axon length (C) and number of branch points per axon (D) for untransfected or cells transfected as indicated. Data represent means 6 s.e.m., n520–25
cells (P50.18, ANOVA). Scale bars: 30 mm.
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CRMP3-independent under our experimental condition. Taken
together, the present findings confirm our in vivo data (Quach
et al., 2008a), and indicate that after neurite initiation has
occurred, CRMP3 can induce dendritic – but not axonal – genesis
in hippocampal neurons. In this aspect, CRMP3 differs from
CRMP2, which affects axon specification and growth (Inagaki
et al., 2001).
CRMP3-mediated dendritic activity is dependent on Ca2+
entry via L- and N-type VGCCs

Journal of Cell Science

We have previously shown that overexpression of CRMP3
increases Ca2+ influx via somatic VGCCs (Quach et al., 2011).
Whether changes in Ca2+ flux affect the dendritic promoting
activity of CRMP3 is unknown. We co-transfected hippocampal
cultures with EGFP or CRMP3 at 3 d.i.v. and assessed dendritic
arbor structure in the presence of inhibitors selective for voltagegated [omega-conotoxin (V-CTX) for N-type VGCCs and
Nifedipine (Nif) for L-type VGCCs] as well as ligand-gated
(APV for NMDARs) Ca2+ influx (Fig. 7A). Using the Sholl
methodology (Fig. 7B–E), we found that blocking Ca2+ influx

via N- and L-type VGCCs in CRMP3-overexpressing neurons
resulted in decreased dendritic complexity compared with
vehicle-treated CRMP3-overexpressing neurons. In contrast,
blocking ligand-gated calcium influx did not. The decrease in
the number of primary dendrites was not significant.
As the sub-cellular distribution of Ca2+ channel types has been
shown to change with phases of neuronal differentiation
(Pravettoni et al., 2000), stage 4 hippocampal neurons were
also analyzed to test for their possible involvement in CRMP3mediated dendrite maintenance. Neurons were cultured for 10
d.i.v. and transfected with EGFP or with EGFP–CRMP3, and
dendritic arbor structure was assessed after incubation with
inhibitors selective for voltage and ligand-gated Ca2+ influx, as
described above. Block of L-type channels with Nifedipine
caused a significant decrease in branching complexity in
CRMP3-transfected neurons compared with EGFP–transfected
neurons [data not shown; P,0.05; Student’s t-test (n540–45
neurons)]. Block of N-type channels or NMDARs did not affect
dendritic complexity [data not shown; P.0.05; one-way
ANOVA with Dunnett’s post-hoc t-test (n540–45 neurons)]

Fig. 7. Involvement of Ca2+ channels in CRMP3 activity and CRMP3-mediated facilitation of depolarization-evoked Ca2+ responses. Block of L- and N-type
Ca2+ channels impairs neurite outgrowth in CRMP3-overexpressing neurons. Representative photo-negative images of cultured cortical neurons transfected with
CRMP3 and EGFP, and incubated with vehicle or Ca2+ channel inhibitors for 24 hours (A). Sholl analysis of neurons overexpressing EGFP (B) or CRMP3 and EGFP
(C) incubated with APV (200 mM), nifedipine (20 mM) or v-conotoxin (1 mM) (B,C). Neurons were transfected at 3 d.i.v.; inhibitors were added 24 hours later and
incubated overnight. The black arrows indicate the peak intersections, observed at about 320 mm from the soma. (D) Peak number of neurite intersections from Sholl
analysis of CRMP3-overexpressing neurons with and without inhibitors. Overnight application of v-conotoxin or nifedipine reduced overall neurite outgrowth
(D) without affecting the length of the longest neurite or the number of primary dendrites (E). n512–21; *P,0.05 (ANOVA). CRMP3 overexpression increases KClstimulated Ca2+ influx in hippocampal neurons. Representative images of hippocampal neurons transfected with CRMP3 and EGFP (F) and loaded with the Ca2+
indicator Fura-2AM 48 hours post transfection (G). Peak response to a high KCl stimulus (H) normalized to baseline values averaged over several minutes before
stimulation. CRMP3 overexpression increased the peak response compared with EGFP alone. Percentage of KCl-induced Ca2+ influx sensitive to block by israpidine.
Israpidine-sensitive Ca2+ influx increased in neurons overexpressing CRMP3 (I). n536–58; *P,0.05, Student’s t-test. Scale bars: 100 mm (A); 30 mm (F,G).

CRMP3, Ca2+ and dendritic growth
during this phase of neurite maintenance, suggesting that the type
of Ca2+ channels involved in CRMP3 dendritic activity varies
with stages of neuronal growth.
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Our results thus far have identified that N- and L-type Ca2+
channels regulate dendritic activity of CRMP3, with L-channels
maintaining activity at a later stage of neuronal differentiation.
So, we tested whether CRMP3 can augment Ca2+ influx and
whether inhibitors of L-type Ca2+ channels can block this effect.
Ca2+-imaging experiments performed with Fura-2AM on EGFPtransfected or EGFP–CRMP3-transfected hippocampal neurons
(Fig. 7F,G) demonstrated that stimulation with high (45 mM)
KCl, a concentration where only CaV1 channels are recruited
(Wheeler et al., 2012), produced a transient rise in intracellular
calcium ([Ca2+]c). Peak calcium influx in response to the
depolarizing stimulus was significantly higher in CRMP3overexpressing neurons (Fig. 7H). KCl-induced Ca2+ influx was
reduced by ,80% in the presence of Israpidine, a
dihydropyridine blocker of L-type Ca2+ channels (Fig. 7I). This
analysis was restricted to the soma of transfected neurons where a
clear enhancement of dendritic complexity induced by CRMP3
could be observed. Collectively then, our results argue for a link
between CRMP3-mediated Ca2+ influx and CRMP3-mediated
dendritic growth.
Discussion
CRMPs constitute a family of proteins expressed abundantly in
the nervous system (Wang and Strittmatter, 1996; Quach et al.,
1997; Quach et al., 2000) involved in the control of growth/
collapse of neurites (Charrier et al., 2003; Schmidt and
Strittmatter, 2007), synaptic activity (Brittain et al., 2009;
Wang et al., 2010; Khanna et al., 2012) and nociceptor
excitability (Piekarz et al., 2012). Five isoforms of CRMPs
have been identified in mammals. Members of this protein family
display 75% homology with each other and 30% homology with
the Unc-33 gene product involved in axonal guidance and
synaptic organization in C. elegans (Li et al., 1992). We have
shown that in dorsal root ganglia (DRG), CRMP1 is required for
the neurite extension induced by neurotrophin-3 (NT3) and
CRMP2 participates in the control of neurite extension in NGFsensitive neurons (Quach et al., 2004). CRMP2 is also necessary
for BDNF and NT3-induced axon outgrowth/branching in
hippocampal neurons (Yoshimura et al., 2005). Manipulation of
CRMPs expression has confirmed their role in neuritogenesis.
Overexpression of CRMP2 in hippocampal neurons induced
supernumerary axons (Inagaki et al., 2001), axon elongation
(Cole et al., 2004) and increased axonal branching (Fukata et al.,
2002), whereas its inhibition with a dominant-negative protein
suppressed the formation of primary axons. Similarly, CRMP5
overexpression induced supernumerary growth cones and
increased collateral axon branching, whereas its inhibition by
siRNA led to a decrease in filopodia and growth cone formation
(Hotta et al., 2005). CRMP5 also interacts with tubulin to
remodel the function of CRMP2 (Brot et al., 2010). However,
perhaps the most significant conceptual advance come from our
CRMP5 and CRMP1 gene targeting in mice: these two members
of the CRMP family, which are distributed in many regions of the
CNS, including the cortex, hippocampus and cerebellum, appear
to play key integrative roles in neuronal migration, learning and
memory (Bretin et al., 2005; Charrier et al., 2006; Yamashita
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et al., 2006) and in neurological diseases (Camdessanche et al.,
2012; Yamashita et al., 2011).
Regarding CRMP3, we first identified the protein as a target
antigen of auto-antibodies present in some patients with
cancer and autoimmune paraneoplastic neurological syndrome
(Honnorat et al., 1999; Knudsen et al., 2007). CRMP3 expression
was also found to be altered in Down syndrome (Weitzdoerfer
et al., 2001). Recent studies revealed that CRMP3 has histone H4
deacetylase (HDAC) activity (Hou et al., 2013). Dendrites are
one of the most plastic structures of the brain. They grow and
retract quickly during development as they look for presynaptic
counterparts to establish the neuronal circuitries. Although their
stability increases in adult brain, dendritic arbors continue to
change, albeit at a slower pace (Purves and Hadley, 1985).
External stimuli such as stress, deprived environment and
depression have been shown to induce reversible retraction of
dendrites in the hippocampus whereas exercise and an enriched
environment increase dendritic complexity (Conrad, 2006).
Consequently, molecules regulating the growth and complexity
of dendrites are likely to play a critical role in neuronal function.
We are studying the role of CRMP3 and possible mechanism of
action on dendrites as a means of understanding the regulation of
dendrite growth or arborization during hippocampal development
and plasticity. In this study, we addressed the function of CRMP3
in neuronal development by using dissociated hippocampal
neurons and found that CRMP3 is essential, not only for
dendrite extension, a late-stage event in the differentiation of
neurons, but also in the early stage of neurite initiation. Neurons
from 1- to 2-day-old hippocampi of control WT mice polarized
and grew normally. Strikingly, all LacZ+-neurons (identified as
neurons by immunopositivity for NF200 and MAP2) from
CRMP32/2 littermates mice exhibited no neurite formation
even after 10 d.i.v. The neuritogenesis defect was mainly a
failure to evolve from stage 1 to stage 2, defined as neurite
initiation. This morphological change was replicated by early
expression of the dominant-negative CRMP3DC. This phenotype
seems specific for CRMP3 because knockdown or targeting of
other CRMPs did not produce the characteristic rounded shape
(Inagaki et al., 2001; Charrier et al., 2006; Yashimata et al., 2011;
Niisato et al., 2012) and because neuritogenesis was not defective
in CRMP3+/2 neurons. As mentioned above, the first step in
neuronal polarization requires establishment of lamellipodia
often considered as a principal means of initiating primary
neurite formation and suggests that its disruption can affect
neuritic outgrowth. However, without primary neurites, neurons
are not able to form axons and dendrites or to accomplish their
ultimate goal of receiving and transmitting information. With
such a scenario, which would provide useful guide for studies
looking for new intrinsic signals that influence the developmental
processes of this structure, one would predict that knockdown or
deletion, and overexpression of proteins inducing lamellipodia in
cultured neurons might ablate or enhance lamellipodia formation,
respectively. Consistent with this idea, we found that in cultured
hippocampal neurons, CRMP3 overexpression promoted
important lamellipodia formation; in contrast, no CRMP32/2
neurons generated lamellipodia and neurites. Altogether, our
studies have established for the first time a link between CRMP3
expression and lamellipodia formation, leading to the notion
that CRMP3 is involved in the patterning of this structure as a
crucial constitutive protein. Indeed, CRMP3 overexpression in
hippocampal neurons significantly increased both dendritic
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Fig. 8. A proposed model for the regulation of dendrite morphology by CRMP3 activity. We propose a model for CRMP3 roles underlying neurite initiation and
dendrite outgrowth throughout Ca2+ influx. Combinatorial stimulation of CRMP3 gene expression or activity by intrinsic and extrinsic factors (1). The localization
and distribution of FL-CRMP3-positive puncta in dendrites suggests that, similar to CRMP2, CRMP3 could be associated with vesicles or large carrier protein
complexes and then actively transported to dendrites (2). Structural and biochemical studies support the idea that CRMP3 activity might be regulated by
phosphorylation or other post-translational modifications (3–4) induced by neurotrophic factors or guidance cues (7). Activated CRMP3 binds to different partners
and serves as adaptor to a variety of signaling pathways including Ca2+ influx (CaV). Our genetic studies showed that CRMP3 contributes to dendrite arborization (5),
spine genesis (6) and neurite initiation (8). These effects might involve lamellipodia formation.

number and length per neuron by approximately twofold. The
correlation between levels of CRMP3 expression and dendrite
extension or spine morphogenesis provides strong support for a
role of CRMP3 in neuronal polarization and plasticity (Quach
et al., 2008a).
The absence of neurites is a common phenotype of CRMP32/2
cells in culture, whereas dendrites are altered but present in vivo
in hippocampal neurons of CRMP32/2 mice (Quach et al.,
2008a; Quach et al., 2008b). The apparent differences in cellular
phenotypes obtained from the identical genotypic background
might be related to adaptive mechanisms and functional
redundancy or compensation between proteins from the same
family in vivo. Guidance cues/neurotrophic factors that possibly
activate other members of the CRMP family or other pathways
leading to neurite formation in CRMP32/2 cells might be present
in living animals but absent in cultured cells, and allow partial
compensatory mechanisms of repair in vivo. In vitro, the
phenotype depends on the time when CRMP3 was suppressed:
CRMP3DC transfection of the cells early after plating induced
aborted protrusions, similar to the ones seen in CRMP32/2
neurons, whereas CRMP3DC transfection at 3 d.i.v. reduced the
length and branching of dendrites. These observations suggest
that if CRMP3 is absent during neurite initiation in vitro, the
process is aborted; however, if CRMP3 is absent after neurite
initiation has occurred, dendrite complexity is affected. Clearly,
both our in vivo and in vitro studies demonstrate a role of CRMP3
on dendrite formation. To our knowledge, our study is the first to
show a direct role for CRMP3 in neuritogenesis. In addition, we
have identified CRMP3DC as a dominant-negative protein.
Neurite initiation and dendrite branching both proceed by the
action of filopodia, which depend on the precisely regulated
polymerization, and crosslinking of actin filaments and on the
structural network of microtubules (Dent et al., 2007). Several
signaling pathways have been proposed for filopodia formation
and most of them involve activation of Rho-family GTPases
(Mattila and Lappalainen, 2008). In addition, actin-bundling
proteins such as fascin and spire proteins, which can crosslink
microtubules and F-actin, are necessary for filopodia formation

(Renault et al., 2008). It is reasonable to hypothesize that CRMP3
might be associated directly or indirectly to these cytoskeletalmodifying structural proteins to promote changes in neurite
morphology through molecular mechanisms that are currently
unknown. Alternatively, a potentially weak adhesion site with
ECM at the leading edge of lamellipodia of CRMP32/2 neurons
might cause a retrograde flow of the lamellipodial cytoskeleton
network that moves the membrane sheet upward as a peripheral
ruffle and inhibit filopodia formation (Chhabra and Higgs, 2007).
In this model, the CRMP32/2 in vitro phenotype of hippocampal
neurons is linked to the absence of specifically required ECM
signaling molecules.
Defining the role of CRMP3 in neurite formation provides
clues on the organizing mechanisms of dendrite morphogenesis
and plasticity, which in turn could explain some
physiopathological aspects of dendritic degeneration. These
hypotheses are supported by our results demonstrating an
important time delay in hippocampal dendrite development in
10-day-old CRMP32/2 pups. Immunocytochemical experiments
(Fig. 1B) revealed a scarcity of neurites, suggesting a
developmental defect in the hippocampus of CRMP32/2 mice,
which might be overcome progressively, albeit partially, with
development over time. Consistent with this argument is the
apparently normal dendritic architecture of hippocampi in
CRMP3+/2 mice, which can be attributed to the selective
expression of the CRMP3 gene. Because the levels of
expression of CRMP3 in hippocampal neurons were associated
with various degrees of dendritogenesis, it is conceivable that
CRMP3 is a key element in neurodegenerative diseases affecting
hippocampal dendrites. Indeed, our previous data clearly
demonstrated that PrP106–126 induced dystrophic changes in
dendrites, and this effect was prevented by overexpression of
CRMP3 (Quach et al., 2011).
In order to gain insights into the mechanism(s) involved in
CRMP3-mediated neurite and dendrite genesis, we explored the
putative involvement of voltage-gated Ca2+ channels. VGCCs
comprise a broad class of membrane channels with a wide variety
of voltage dependence, activation and inactivation properties, and
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CRMP3, Ca2+ and dendritic growth
are critical contributors to Ca2+ signaling within dendrites and
spines in both physiological and pathological conditions
(McCutchen et al., 2002; Benarroch, 2010). In hippocampal
pyramidal neurons, dendritic VGCCs include L-, N-, P/Q- and Rtype Ca2+ channels, which open following strong synaptically
evoked depolarization (Striessnig and Koschak, 2008). Here,
we used fluorescent Ca2+ imaging in combination with
pharmacological assays to define the VGCC subtypes
associated with CRMP3 dendritic activity. We observed that
Ca2+ influx elicited by KCl is significantly increased in EGFP–
CRMP3-transfected cells when compared with EGFP-transfected
controls (Fig. 7H), highlighting a possible role of CRMP3 as a
direct regulator of Ca2+ influx through VGCCs. Pharmacological
experiments revealed the involvement of L-type Ca2+ channels,
probably via an association between L-type Ca2+ influx and
dendrite arborization induced by CRMP3. Additional studies
demonstrated that inhibiting L-type Ca2+ channels strongly
altered dendrite arbor of hippocampal neurons at various stages
(Fig. 7A–D), positioning this channel as a regulator of dendrite
development during neuronal differentiation. Taken together, our
results identify CRMP3 as an important determinant of the
development of appropriate dendritic arbor requiring influx of
Ca2+ via L-type Ca2+ channels (see proposed model in Fig. 8)
and raise the intriguing possibility of targeting these channels as a
way to develop clinically useful therapies for neurodegenerative
diseases involving dendritic impairment.
Materials and Methods
Mouse breeding and genotyping

The 129SvE CRMP32/2 line was established in the transgenic mouse facilities of
Ohio State University (Quach et al., 2008a). All experiments were conducted in
accordance with the guidelines of the National Institutes of Health, USA.
Genotyping was performed by PCR on DNA extracted from ear or tail clips after
proteinase K digestion. Sequences corresponding to the insertion were amplified
using Taq polymerase (Promega, WI) with sets of primers for LacZS/LacZA or
NeoS/NeoA
derived
from
the
LacZ
(LacZS:AGCAGAAGCCGTCGATGTCG, LacZA:ACCGTTCATACAGAACTGG) or Neomycin (NeoS:CCGACCTGTCCGGTGCCCTGAATGAA, NeoA:TACCGTAAAGCACGAGGAAGCGGTCA) sequences and primers from the intronic regions surrounding exon 3
(P3:GGCAGATAGGTAACCATTTGG, P4:GCATTTACAGAAACCCAGC).
Cell culture

WT, CRMP3+/2 and CRMP32/2 hippocampal cells were prepared following a
modification of the methods of Banker and Cowan (Banker and Cowan, 1979).
Briefly, 1 and 2 postnatal day old hippocampi were dissected, digested with 16
trypsin-EDTA (pH 7.2; Invitrogen, Carlsbad, CA) for 30 minutes at 37 ˚C, rinsed
five times with Neurobasal to remove trypsin, followed by trituration with pipettes.
Dissociated neurons were plated at a density of 1–36104 cells/ml onto poly-Llysine (50 mg/ml)/laminin (10 mg/ml, Sigma, St Louis, MO) coated Lab-Tek eightwell chamber slides (Nunc International, NJ). After plating for 20 minutes,
medium was replaced with neuronal culture medium (0.5 mM glutamine, 100 U/
ml penicillin-streptomycin in neurobasal medium supplemented with 1% B27, 1%
N2 and 0.5% glucose) to remove debris. Cultures were maintained in a humidified
atmosphere of 5% CO2 in air at 37 ˚C, and cells were analyzed at 6 or 10 d.i.v.
Molecular constructs

The C- or N-terminally truncated mutants were generated from full-length FLAGCRMP3 (FL-CRMP3) by PCR with specific primers (P-DNs: 59-ACGCGGATCCATGTCCTTCCAAGGC; P-DNas: 59-GGACTAGTCTAGATGTTGTACTCTAC; P-DCs: 59-ACGCGGATCCGACTACTCCTTAC; P-DCac: 59-GGACTAGTCTAGGAAAGAGACGTG) introducing BamHI and SpeI sites at the 59 and
39 end, respectively. PCR products were purified and directionally inserted into the
pCMV2Flag vector (Sigma) which generated a protein with a FLAG tag at its Nterminus. The correct DNA sequences of both constructs were verified by
sequencing. Plasmid DNAs were purified using Qiagen kit (Gaithersburg, MD).
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HBS, then adjusted with H2O to a volume of 50 ml. To avoid the formation of big
crystals of Ca2+, 1/5 volume of solution A (plasmid DNA, CaCl2, H2O) was added
at a time into solution B (26 HBS) followed by pipetting several times and gentle
vortexing. The mixed solution was kept at room temperature for 20 minutes before
being added to each well. After incubation for 3–5 hours, the calcium phosphate
precipitate was dissolved with 400 ml transfection medium pre-equilibrated in a
10% CO2 incubator for 50–60 minutes to reduce cell toxicity. After incubation for
15–20 minutes, medium was replaced with cultured Neurobasal medium
(supplemented with B27, 0.5 mM glutamine, and 100 U/ml penicillinstreptomycin; Invitrogen) and cultures maintained in a 5% CO2 incubator at
37 ˚C. For CRMP3 knockdown by siRNA, hippocampal neurons were transfected
with full-length CRMP3 and either siRNA-CRMP3 (59-UCUUGCUCCAGUAGUGUGAGC-39) or scrambled siRNA (UUCUCCGAACGUGUCACGU), as
previously described (Hou et al., 2006; Brot et al., 2010). The co-transfections
were performed with the simultaneous use of Ribojuice and Nanojuice kits
(Novagen, Morgantown, WV).
Immunocytochemistry and X-gal staining

Cells were fixed, permeabilized with 0.1% Triton X-100 in PBS containing 1%
gelatin and stained with anti-b galactosidase (Promega; 1:500) or anti-FLAG
(Sigma; 1:10,000) and anti-MAP2 (Frontier Science, Co, Wisconsin, WI; 1:700),
or anti-Tau (Santa Cruz, CA; 1:500) antibodies. Cells were then incubated with
one or more of the secondary antibodies (Alexa-Fluor-546-coupled anti-rabbit IgG
and Alexa-Fluor-488-coupled anti-mouse IgG; 1:2000, Molecular Probes, OR).
Some cultures were incubated with a 0.1 mg/ml solution of DAPI (4,6-diamidino2-phenylindoldihydrochloride, Sigma) to label cell nuclei. For X-gal staining, cells
were permeabilized with 0.1% Triton X-100 in PBS containing 1% gelatin, and
stained with X-gal solution (5 mM potassium ferricynide, 5 mM potassium
ferrocyanide, 2 mM MgCl2, and 1 mg/ml 5-bromo-4-chloro-3-indoyl-beta-Dgalactopyranoside in PBS) at 37 ˚C for 10–12 hours.
Fura-2AM Ca2+ imaging

Ca2+ imaging experiments were performed on neurons transfected with CRMP3
plus green fluorescent protein (EGFP) or EGFP alone (InVitrogen). Neurons were
loaded with 3 mM Fura-2AM (in Tyrode’s buffer 119 mM NaCl, 2.5 mM KCl,
2 mM CaCl2, 2 mM MgCl2, 25 mM HEPES, pH 7.5, 30 mM glucose) for
25 minutes at room temperature in the dark (Wang and Khanna, 2011; Wilson
et al., 2012). Neurons were then washed three times with Tyrode’s buffer.
Experiments were performed on the stage of a Nikon Ti Eclipse inverted
microscope equipped with a Lambda DG-4 175 W xenon lamp and a Nikon 620,
0.4 N.A. epifluorescence objectives. Fura-2 (excitation: 340, 380 nm; emission:
510 nm) ratio images were acquired, every 10 seconds, with an intensified CCD
camera Cascade 512B digital camera (Photomometrics, Tucson, AZ) and digitized
(2566512 pixels) using Nikon Elements Software (Nikon Instruments, Melville,
NY). After a baseline of at least six images was obtained, neurons were stimulated
by addition of excitatory Tyrode’s buffer (32 mM NaCl, 90 mM KCl, 2 mM
CaCl2, 2 mM MgCl2, 25 mM HEPES pH 7.5, 30 mM glucose) to a final
concentration of 45 mM KCl. Background fluorescence from a cell-free region
was subtracted from each 340 nm and 380 nm image. Calibrated values were
obtained in situ by determining Fmin (10 mM EGTA in Ca2+ free-solution) and
Fmax (10 mM ionomycin in 10 mM Ca2+ solution; the protonophore ptrifluoromethoxy-phenylhydrazone (FCCP, 2 mM) was given before ionomycin
to greatly reduce Ca2+ buffering. A Kd of 224 nM was used in the ratio method
equation [Ca2+]I5Kd*(F380max/F380min)*(R–Rmin)/(R–Rmax), where R5F340/F380
(Piekarz et al., 2012). Cells whose Ca2+ responses were smaller than KCl (when
challenged with ionomycin) and those whose Ca2+ responses were larger than
initial baseline (when challenged with EGTA) were not included in the dataset.
Image capture and neurite quantification

Slides were coded before quantitative analysis by a blind-rater. Images of
immunofluorescent neurons were taken with Axioplan II fluorescence microscope
(Carl Zeiss) using 10, 20, 40 or 1006 lens then quantified with image-analyzing
software (Metamorph, Universal Imaging or Soft Imaging System, SIS). For
fluorescence analysis, three views of the same section were recorded using
appropriate filters, as black and white images, which were then color-coded green
(SNAT2), red (phenotypic markers) or blue (cell nuclei) by the software and
merged together as indicated. Neurites (defined as length $ cell body), number of
dendrites and branches, total dendrite length per cell and length of longest dendrite
were measured. The length of each dendrite was measured by tracing along its
length and the lengths subsequently summed for total dendritic length. In some
experiments, similar measurements were made for axons.
Sholl analysis of dendritic complexity

Transfection assays

The calcium phosphate DNA complex was prepared following the Clontech
Calphos mammalian transfection kit manufacturer’s protocol (BD Bioscience, Palo
Alto, CA, USA). 1 mg of plasmid DNA was mixed with 3.1 ml 2 M CaCl2 and 26

Neurite outgrowth of neurons transfected with EGFP or CRMP3 + EGFP and
incubated in the presence of various drugs or 0.01% DMSO (control), was assessed
as previously described (Brittain et al., 2011; Wang et al., 2010). Transfection of
EGFP into neurons allowed optical identification and unequivocal determination
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of their arborizations. Images were acquired with a Nikon Eclipse 90i microscope
by an experimenter blinded to transfection conditions.
Statistics

A parametric one-way or two-way ANOVA followed by Newman–Keuls or
independent Student’s t-test or a non-parametric one-way or two-way ANOVA
followed by a Dunn test or Mann–Whitney test were applied. GB-STAT, and
GraphPad-InSTat software were used with significance set at P,0.05.
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(2009). The stimulation of dendrite growth by Sema3A requires integrin engagement
and focal adhesion kinase. J. Cell Sci. 122, 2034-2042.
Schmidt, E. F. and Strittmatter, S. M. (2007). The CRMP family of proteins and their
role in Sema3A signaling. Adv. Exp. Med. Biol. 600, 1-11.
Shelly, M., Cancedda, L., Heilshorn, S., Sumbre, G. and Poo, M. M. (2007). LKB1/
STRAD promotes axon initiation during neuronal polarization. Cell 129, 565-577.
Song, H. J. and Poo, M. M. (1999). Signal transduction underlying growth cone
guidance by diffusible factors. Curr. Opin. Neurobiol. 9, 355-363.
Striessnig, J. and Koschak, A. (2008). Exploring the function and pharmacotherapeutic
potential of voltage-gated Ca2+ channels with gene knockout models. Channels 2,
233-251.
Van Aelst, L. and Cline, H. T. (2004). Rho GTPases and activity-dependent dendrite
development. Curr. Opin. Neurobiol. 14, 297-304.
Vanderhaeghen, P. and Polleux, F. (2004). Developmental mechanisms patterning
thalamocortical projections: intrinsic, extrinsic and in between. Trends Neurosci. 27,
384-391.
Varrin-Doyer, M., Vincent, P., Cavagna, S., Auvergnon, S., Noraz, N., Rogemond,
V., Honnorat, J., Moradi-Ameli, M. and Giraudon, P. (2009). Phosphorylation of
CRMP2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration. J. Biol.
Chem. 284, 13265-13276.
Wang, Y. and Khanna, R. (2011). Voltage-gated calcium channels are not affected by
the novel anti-epileptic drug lacosamide. Transl. Neurosci. 2, 13-22.
Wang, L. H. and Strittmatter, S. M. (1996). A family of rat CRMP genes is
differentially expressed in the nervous system. J. Neurosci. 16, 6197-6207.
Wang, Y., Brittain, J. M., Wilson, S. M. and Khanna, R. (2010). Emerging roles of
collapsin response mediator proteins (CRMPs) as regulators of voltage-gated calcium
channels and synaptic transmission. Commun. Integr. Biol. 3, 172-175.
Weitzdoerfer, R., Fountoulakis, M. and Lubec, G. (2001). Aberrant expression of
dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain.
J. Neural Transm. Suppl. 61, 95-107.
Wheeler, D. G., Groth, R. D., Ma, H., Barrett, C. F., Owen, S. F., Safa, P. and Tsien,
R. W. (2012). Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+)
signaling to control CREB-dependent gene expression. Cell 149, 1112-1124.
Wilson, S. M., Schmutzler, B. S., Brittain, J. M., Ripsch, M. S., Hingtgen, C. M.,
White, F. A. and Khanna, R. (2012). Inhibition of transmitter release and
attenuation of AIDS therapy induced painful synthetic Ca2+ channel peptides. J. Biol.
Chem. 287, 35065-35077.
Yamaguchi, H., Shiraishi, M., Fukami, K., Tanabe, A., Ikeda-Matsuo, Y., Naito,
Y. and Sasaki, Y. (2009). MARCKS regulates lamellipodia formation induced by
IGF-I via association with PIP2 and beta-actin at membrane microdomains. J. Cell.
Physiol. 220, 748-755.
Yamashita, N., Uchida, Y., Ohshima, T., Hira, S., Nakamura, F., Taniguchi, M.,
Mikoshiba, K., Honnorat, J., Kolattukudy, P. et al. (2006). CRMP1 mediates reelin
signaling in cortical neuronal migration. J. Neurosci. 26, 13357-13362.
Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A. and Kaibuchi,
K. (2005). GSK-3b regulates phosphorylation of CRMP-2 and neuronal polarity. Cell
120, 137-149.
Yu, L. M. and Goda, Y. (2009). Dendritic signalling and homeostatic adaptation. Curr.
Opin. Neurobiol. 19, 327-335.

